Clinical trial
Treatment of Leiomyomata With the Selective Progesterone Receptor Modulator CDB-2914
NCT00044876 is registered in ClinicalTrials.gov with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Leiomyomata With the Selective Progesterone Receptor Modulator CDB-2914
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 2, 2002
- Completion date
- October 1, 2015
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.